Target intelligence / Profile preview

Novel transcript, antisense to AKR1C4 (ENSG00000287848)

Target
ENSG00000287848
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other (not a protein, not a conventional receptor, enzyme, transporter, etc.)
01

Overview

ENSG00000287848 encodes a long non-coding RNA termed "novel transcript, antisense to AKR1C4" (also known as AL355303.2), transcribed in the antisense orientation relative to the protein-coding gene AKR1C4[3][9]. Antisense lncRNAs such as this are known to regulate gene expression, often by influencing the transcription, processing, or stability of the corresponding sense mRNA through mechanisms related to chromatin modification and transcriptional interference[2][4][6]. While global studies demonstrate that antisense transcription can modulate chromatin structure and sense transcript dynamics, there is no direct evidence linking this specific lncRNA to a distinct gene regulatory or disease role, nor is it currently regarded as a therapeutic target. Its main significance may lie in the broader biological context of antisense RNA regulation rather than as an individual druggable entity.

Other names
AL355303.2ENSG00000287848
02

Biological functions

Regulation of gene expression through antisense transcriptionModulation of chromatin environment near AKR1C4, potentially influencing sense transcript production, processing, and stabilityOther (no protein or catalytic activity)
03

Disease associations

Other/Unknown. No direct evidence or established links to specific diseases for this transcript in current knowledge bases

Beyond the preview

Go deeper on Novel transcript, antisense to AKR1C4 (ENSG00000287848).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to AKR1C4 (ENSG00000287848).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call